Dosimetry for radiopharmaceutical therapy: Current practices and commercial resources Review


Authors: Capala, J.; Graves, S. A.; Scott, A.; Sgouros, G.; James, S. S.; Zanzonico, P.; Zimmerman, B. E.
Review Title: Dosimetry for radiopharmaceutical therapy: Current practices and commercial resources
Abstract: With the ongoing dramatic growth of radiopharmaceutical therapy, research and development in internal radiation dosimetry continue to advance both at academic medical centers and in industry. The basic paradigm for patient-specific dosimetry includes administration of a pretreatment tracer activity of the therapeutic radiopharmaceutical; measurement of its time-dependent biodistribution; definition of the pertinent anatomy; integration of the measured time-activity data to derive source-region time-integrated activities; calculation of the tumor, organ-at-risk, and/or whole-body absorbed doses; and prescription of the therapeutic administered activity. This paper provides an overview of the state of the art of patient-specific dosimetry for radiopharmaceutical therapy, including current methods and commercially available software and other resources. © 2021 by the Society of Nuclear Medicine and Molecular Imaging.
Keywords: radiopharmaceuticals; tissue distribution; dosimetry; radiopharmaceutical agent; radiometry; phantoms, imaging; spect; imaging phantom; radiopharmaceutical therapy
Journal Title: Journal of Nuclear Medicine
Volume: 62
Issue: Suppl. 3
ISSN: 0161-5505
Publisher: Society of Nuclear Medicine  
Date Published: 2021-12-01
Start Page: 3S
End Page: 11S
Language: English
DOI: 10.2967/jnumed.121.262749
PUBMED: 34857621
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 1 February 2022 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Pat B Zanzonico
    355 Zanzonico